Public Health

CHICAGO – October 30, 2026 -- The American Lung Association Research Institute has invested $21 million in research and related scientific activities this year, bringing its total direct research funding over the past decade to $193 million.

More than $11 million goes to 120 research projects

The $21 million covers direct research funding of more than $11 million for 120 projects, plus related scientific activities. The projects run through three programs: the Awards and Grants Program, the Airways Clinical Research Centers Network and the Accelerator Program. The $193 million ten-year figure also includes the infrastructure and scientific support needed to advance research.

BOSTON – October 30, 2026 -- Nearly 150 million Americans now live in areas with unhealthy air quality, according to a new issue brief from nonprofit consultancy FSG that urges funders and policymakers to back community-led respiratory health programs.

The brief, titled "Improving Community Respiratory Health: Place-Based Lessons from the Field," was released in recognition of Lung Health Day. It draws on research and interviews with leaders from community-based organizations, philanthropy, healthcare and advocacy groups.

Six elements define effective place-based respiratory models

FSG identifies six common characteristics of successful models:

TOKYO – October 29, 2026 -- The Global Health Innovative Technology (GHIT) Fund has committed about JPY 1.06 billion (USD 6.8 million) to nine R&D projects covering drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NTDs) and emerging infectious diseases such as Ebola.

Trachoma rapid test receives JPY 450 million for clinical validation and launch

The largest single award, about JPY 450 million (USD 2.9 million), goes to a point-of-care rapid diagnostic test for trachoma. The project is led by Drugs and Diagnostics for Tropical Diseases, Medical & Biological Laboratories (MBL), The Carter Center and Big Eye Diagnostics, and has received GHIT support since 2024.

United States – October 29, 2026 -- Influenza-associated hospitalizations reached 3.5 per 1,000 hospitalizations in the week beginning September 21, 2026, nearly three times the next-highest rate recorded at the same point in the prior six flu seasons, according to a Truveta Data analysis.

Hospitalization rate climbs more than 2.5 times faster than in any prior season

From the week beginning August 31 through the week beginning September 21, the rate rose by an average of 0.7 hospitalizations per 1,000 each week. The next-fastest increase over the comparable period was 0.3 per 1,000 per week, in 2022–23.

Across the six prior seasons, the median weekly change at this point was −0.03 per 1,000. Hospitalization rates were generally stable or declining at this stage of past seasons.

United States – October 29, 2026 -- The rate of e-bike-related emergency department (ED) visits rose 760.2% between January–August 2023 and January–August 2026, while traditional bicycle visits increased only 7.9%, according to a Truveta Data analysis.

E-bike visits climbed from 1.2 to 10.1 per 100,000 people with an ED visit. The traditional bicycle rate moved from 59.4 to 64.1 per 100,000. Traditional bicycles still dominate in absolute volume: the study period recorded 63,811 traditional bicycle ED visits against 4,769 for e-bikes.

Pediatric e-bike ED visit rate rises 19.1-fold to 35.7 per 100,000

Patients aged 0–17 saw the steepest increase, from 1.9 to 35.7 per 100,000, against a 1.5-fold rise for traditional bicycles in the same group. E-bike rates also grew 7.7-fold among 18–24-year-olds, 7.4-fold among 25–44-year-olds, 7.6-fold among 45–64-year-olds and 3.2-fold among those 65 and older.

Athens – October 27, 2026 -- Month 6 interim data comparing single-dose Cecolin 9 with Gardasil 9 were presented at the 38th Annual Conference of the International Papillomavirus Society (IPVS 2026), while final results from the Phase III SHINE I study are not expected until 2028.

Navrongo researcher presents Month 6 analysis of PATH's SHINE I study

Dr. Nana A. Ansah of Ghana's Navrongo Health Research Centre presented the interim analysis of PATH's Single-dose HPV Immunobridging Study with New Vaccines (SHINE I; CVIA 104). The Phase III, double-blind, randomized, multinational study runs in Ghana and the Philippines. It compares the immunogenicity and safety of single-dose Cecolin 9, developed by Xiamen Innovax Biotech Co., Ltd. (IX), with Gardasil 9.

Participants include girls aged 9–14 and young women aged 15–20.

Fairfax – – October 19, 2026 -- Allergy & Asthma Network will hold the 12th annual USAsthma Summit on Nov. 13, 2026, in Phoenix, Arizona, with free registration for both in-person and livestream attendees.

The one-day event targets public health professionals, clinicians, asthma educators, respiratory therapists, patients, caregivers, advocates and community partners. The organizer says policymakers are considering changes that could affect access to asthma care, and the Summit is meant to address those challenges.

Summit runs alongside the ACAAI Annual Scientific Meeting in Phoenix

The event coincides with the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in the same city. That timing creates additional engagement opportunities for attendees, speakers and leaders in allergy, asthma and immunology.

Irvine, Calif. – October 07, 2026 -- MAXAIR Systems will supply a substantial quantity of its CAPR® helmet systems and related disposable equipment to World Vision for Ebola response efforts in the Democratic Republic of the Congo.

MAXAIR deepens 25-year partnership with World Vision on frontline protective gear

The Irvine, Calif.-based respiratory protection manufacturer confirmed the contribution is intended for healthcare professionals, humanitarian workers and other frontline teams operating in communities affected by the outbreak in the Democratic Republic of the Congo.

Los Angeles – – October 06, 2026 -- Vision To Learn has provided 300,000 children in California with free glasses, a milestone marked today at 24th Street Elementary School alongside the launch of a new initiative to outfit every child in Los Angeles Unified's Community Schools.

Nonprofit marks 300,000-glasses milestone with LA Unified officials

Founder Austin Beutner, California Teachers Association President David Goldberg, and LA Unified Superintendent Andrés E. Chait joined the event. Vision To Learn operates mobile vision clinics staffed by licensed eye care professionals, delivering screenings, exams and glasses directly at schools in low-income communities at no cost to families.

New York – October 05, 2026 -- A new multisector coalition launched the 30x30x50 Brain Challenge, pledging to cut stroke incidence by 30 percent and increase primary-care cognitive screening by 50 percent across 30 global cities by 2031.

Atria-coordinated coalition unites pharma, tech and the UN behind brain health delivery

The International Brain Health Coalition (IBC), coordinated by the Atria Research and Global Health Institute (ARGHI), brings together patients, multilateral institutions including the United Nations, and organizations spanning medicine, technology, and finance. Collaborators include Eli Lilly and Company, Bristol Myers Squibb, Microsoft, the Royal Bank of Canada, the American Heart Association, UN Women, Western University, and the AI-Mind Institute in Norway.